← Leaderboards
Esther Seunghee Oh
Johns Hopkins University
$5,646,106
Attributed
$7,720,745
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,720,745 · 6
By mechanism
R01$5,922,165 · 3
K23$818,775 · 1
T32$611,573 · 1
R21$368,232 · 1
Top collaborators
- Carrie L Nieman4 shared
- Suzanne Craft2 shared
- Peter M. Abadir1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Charles C Della Santina$18,969,063
- Yuri Agrawal$7,705,031
- Yuan-Xiang Tao$12,887,850
- Robert P Schleimer$28,154,309
- Charles Hugh Brown$3,225,774
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseMild Cognitive ImpairmentDementiaSamplingMeasurementLongitudinal StudiesAmyloid Beta-ProteinDisease ProgressionPathologyNursing HomesResponseSeveritiesFunctional DeclineMethodologyBaseBrainCaringInsightOutpatientsBiological MarkersCerebrospinal FluidIncidencePre-Clinical
Grant awards (18)
Addressing Hearing Loss as a Common Unmet Contributor to Neuropsychiatric Symptoms$752,953
R01 · FY2025 · AG · contact PI
Translational Aging Research Training Program$611,573
T32 · FY2025 · AG
Addressing Hearing Loss as a Common Unmet Contributor to Neuropsychiatric Symptoms$791,348
R01 · FY2024 · AG · contact PI
Addressing Hearing Loss as a Common Unmet Contributor to Neuropsychiatric Symptoms$806,858
R01 · FY2023 · AG · contact PI
Addressing Hearing Loss as a Common Unmet Contributor to Neuropsychiatric Symptoms$818,314
R01 · FY2022 · AG · contact PI
Does vestibular loss predict falls in patients with Alzheimer's Disease?$323,597
R01 · FY2022 · AG · contact PI
Clinical and Biological Predictors of Delirium and Long-term Cognitive Outcomes in COVID19 Patients$197,204
R01 · FY2021 · AG · contact PI
Novel Blood Biomarker of Alzheimer's disease Using Oral Glucose Tolerance$645,291
R01 · FY2020 · AG · contact PI
Novel Blood Biomarker of Alzheimer's disease Using Oral Glucose Tolerance$618,689
R01 · FY2019 · AG · contact PI
Novel Blood Biomarker of Alzheimer's disease Using Oral Glucose Tolerance$557,671
R01 · FY2018 · AG · contact PI
Novel Blood Biomarker of Alzheimer's disease Using Oral Glucose Tolerance$410,240
R01 · FY2017 · AG · contact PI
CSF predictors of postoperative delirium in non-demented hip fracture patients$163,755
K23 · FY2016 · AG · contact PI
CSF predictors of postoperative delirium in non-demented hip fracture patients$163,755
K23 · FY2015 · AG · contact PI
CSF predictors of postoperative delirium in non-demented hip fracture patients$163,755
K23 · FY2014 · AG · contact PI
CSF predictors of postoperative delirium in non-demented hip fracture patients$163,755
K23 · FY2013 · AG · contact PI
CSF predictors of postoperative delirium in non-demented hip fracture patients$163,755
K23 · FY2012 · AG · contact PI
Oral Glucose Tolerance Test for Alzheimer's Disease Biomarker Development$191,060
R21 · FY2011 · AG · contact PI
Oral Glucose Tolerance Test for Alzheimer's Disease Biomarker Development$177,172
R21 · FY2010 · AG · contact PI